Mitsui Chemicals Consolidates Japanese Dental 3D Printing Business Under Sun Medical

Mitsui Chemicals has decided to integrate its dental 3D printing business and some dental materials business in Japan into subsidiary Sun Medical Co., Ltd., which will become the core of its dental 3D printing operations. Kulzer Japan Co., Ltd. will also transfer its 3D printer and 3D printing materials business into Sun Medical, consolidating research, development, manufacturing and sales in Japan. Ultradent is scheduled to become a shareholding in September 2026.

Key facts

Market context

Photopolymer resins and related materials are the core inputs for dental 3D printing, where they are cured layer by layer to produce crowns, dentures, surgical guides, aligner models and other clinical parts. Demand is driven mainly by dental clinics and dental laboratories that want faster, lower-cost production than traditional casting and milling, and by the growing use of digital workflows in restorative and prosthetic dentistry. Because printer hardware and the resins used in it are often sold as a matched system, consolidating printers, materials and sales under one maker can simplify product approval, technical support and distribution. For chemical buyers, this kind of move tends to concentrate supply of specialised dental resins among fewer suppliers, which can affect pricing, product lineups and the pace at which new materials reach the market. Competitors in dental materials and printing systems typically respond by strengthening their own distribution and product certification.

Source: official release on jp.mitsuichemicals.com. Summary and context written by Market Krystal.